Pharmaceutical

Filter

Current filters:

None

Popular Filters

130 to 154 of 7221 results

UCB’s Phase III results for Neupro will back filing in China this year

UCB’s Phase III results for Neupro will back filing in China this year

05-02-2015

Belgian drugmaker UCB has announced positive top-line results from two Phase III studies of Neupro (rotigotine…

ChinaNeuproNeurologicalPharmaceuticalResearchUCB

HER-2 negative breast cancer market to quadruple by 2023, says GlobalData

HER-2 negative breast cancer market to quadruple by 2023, says GlobalData

05-02-2015

The market value for therapeutics to treat HER2-negative breast cancer will increase more than fourfold…

AstraZenecaGlobalDataLynparzaOncologyPfizerPharmaceutical

Lundbeck posts 4th-qtr and full-year 2014 loss, but sees brighter future

05-02-2015

Danish CNS specialist Lundbeck (LUN: CO) reported fourth-quarter 2014 sales of 3.25 billion Danish kroner…

FinancialLundbeckNeurologicalPharmaceutical

Australian Intergenerational Reports have misrepresented PBS expenditure: Medicines Australia

Australian Intergenerational Reports have misrepresented PBS expenditure: Medicines Australia

04-02-2015

The Intergenerational Reports on aging from the Australian government have seriously overestimated Pharmaceutical…

AustraliaMarkets & MarketingMedicines AustraliaPharmaceuticalPolitics

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

04-02-2015

UK pharma major GlaxoSmithKline saw its shares rise 2.8% to £14.94 shortly after reporting fourth-quarter…

Core EPsFinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

Merck & Co financials hit by patent expiries and strong dollar

Merck & Co financials hit by patent expiries and strong dollar

04-02-2015

US pharma giant Merck & Co reported 2014 financial, showing that revenue for the fourth quarter declined…

FinancialMerck & CoPharmaceutical

Karolinska Institutet establishes research base in Hong Kong and China after record donation

04-02-2015

Sweden’s Karolinska Institutet is to set up its own research base in Hong Kong. This initiative is…

ChinaFinancialPharmaceuticalResearch

Kite Pharma expands its leadership team with two new appointments

Kite Pharma expands its leadership team with two new appointments

04-02-2015

Autologous T-cell therapy product specialist Kite Pharma has appointed Salah Kivlighn as vice president…

Anthony PolverinoBoardroomKite PharmaPharmaceuticalSalah Kivlighn

Early FDA approval for Pfizer breast cancer drug Ibrance

Early FDA approval for Pfizer breast cancer drug Ibrance

04-02-2015

The US Food and Drug Administration yesterday granted accelerated approval for pharma giant Pfizer’s…

IbranceOncologyPfizerPharmaceuticalRegulationUSA

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

04-02-2015

Swiss drug major Roche has announced positive results from the Phase III study of Gazyva (obintuzumab)…

GazyvaOncologyPharmaceuticalResearchRoche

Novartis' Japan unit faces 15-day suspension over trial data manipulation

Novartis' Japan unit faces 15-day suspension over trial data manipulation

04-02-2015

The Japanese unit of Swiss drug major Novartis is facing suspension following allegations of data manipulation…

DiovanHematologyJapanLegalNovartis PharmaceuticalsOncologyPharmaceuticalRegulation

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

04-02-2015

US drugmaker Isis Pharmaceuticals has announced top-line results from a Phase II study of ISIS-PTP1BRx…

DiabetesIsis PharmaceuticalsPharmaceuticalResearchUSA

Bleaker future for men with prostate cancer in England

04-02-2015

Today marks World Cancer Day, which this year focuses on “achieving treatment for all.” However,…

FinancialHealthcareJevtanaOncologyPharmaceuticalSanofiUK

Sanofi and MannKind's Afrezza now available in the USA

Sanofi and MannKind's Afrezza now available in the USA

03-02-2015

The only inhaled insulin Afrezza (human insulin) Inhalation Powder, developed by French drug major Sanofi…

AfrezzaDiabetesMannKindMarkets & MarketingPharmaceuticalSanofiUSA

Chugai to expand Singapore R&D unit with $476 million investment

03-02-2015

Japan's Chugai Pharmaceutical, which is majority owned by Swiss pharma giant Roche, plans to invest $476…

Chugai PharmaceuticalFinancialPharmaceuticalResearchRocheSingapore

Arena and Ildong receive marketing authorization for obesity drug Belviq in South Korea

Arena and Ildong receive marketing authorization for obesity drug Belviq in South Korea

03-02-2015

US biopharma company Arena Pharmaceuticals has received marketing authorization in South Korea for Belviq…

Arena PharmaceuticalsBelviqIldong PharmaMetabolicsPharmaceuticalRegulation

US FDA seeks 9% budget hike to $4.9 billion for FY 2016

US FDA seeks 9% budget hike to $4.9 billion for FY 2016

03-02-2015

The US Food and Drug Administration is requesting a budget of $4.9 billion to protect and promote the…

FinancialPharmaceuticalRegulationUSA

Ipsen reports strong performance by specialty care and solid overall growth for 2014

Ipsen reports strong performance by specialty care and solid overall growth for 2014

03-02-2015

French drugmaker Ipsen has reported solid growth for 2014, driven by good performance in its specialty…

DecapeptylDysportFinancialFranceIpsenPharmaceuticalSomatuline

Sparse pipeline for acromegaly and gigantism treatment limiting market growth

03-02-2015

The acromegaly and gigantism treatment market will expand at a modest compound annual growth rate (CAGR)…

EuropeMarkets & MarketingMetabolicsNovartisPfizerPharmaceuticalSandostatin LARSigniforSomavertUSA

US government seeks to negotiate Medicare prices of high-cost medicines

US government seeks to negotiate Medicare prices of high-cost medicines

03-02-2015

The Obama Administration wants to win the authority to negotiate over the prices of specialty drugs for…

FinancialPatentsPharmaceuticalPoliticsPricingUSA

FDA approves Boehringer Ingelheim and Eli Lilly's Glyxambi for type 2 diabetes

FDA approves Boehringer Ingelheim and Eli Lilly's Glyxambi for type 2 diabetes

02-02-2015

The US Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets from German…

Boehringer IngelheimDiabetesEli LillyGlyxambiPharmaceuticalRegulation

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

02-02-2015

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Commission…

Men's HealthPharmaceuticalRegulationSobiXiaflexXiapex

Helsinn grants Stendhal rights to NEPA in several Latin America countries

02-02-2015

Family-run Swiss oncology specialist Helsinn has granted exclusive rights to Mexico-based Especificos…

AkynzeoEisaiHelsinnLicensingNEPAnetupitantOncologypalonosetronPharmaceuticalSouth AmericaStendhal

130 to 154 of 7221 results

COMPANY SPOTLIGHT

Menarini

Back to top